171 related articles for article (PubMed ID: 28374252)
1. Alphavirus-Based Vaccines.
Lundstrom K
Methods Mol Biol; 2017; 1581():225-242. PubMed ID: 28374252
[TBL] [Abstract][Full Text] [Related]
2. Alphavirus-Based Vaccines.
Lundstrom K
Methods Mol Biol; 2016; 1404():313-328. PubMed ID: 27076308
[TBL] [Abstract][Full Text] [Related]
3. Alphavirus-based vaccines.
Lundstrom K
Viruses; 2014 Jun; 6(6):2392-415. PubMed ID: 24937089
[TBL] [Abstract][Full Text] [Related]
4. Alphavirus-Based Antigen Preparation.
Lundstrom K
Methods Mol Biol; 2021; 2183():63-81. PubMed ID: 32959241
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
6. Application of Alphaviral Vectors for Immunomodulation in Cancer Therapy.
Zajakina A; Spunde K; Lundstrom K
Curr Pharm Des; 2017; 23(32):4906-4932. PubMed ID: 28641531
[TBL] [Abstract][Full Text] [Related]
7. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
Pushko P; Geisbert J; Parker M; Jahrling P; Smith J
J Virol; 2001 Dec; 75(23):11677-85. PubMed ID: 11689649
[TBL] [Abstract][Full Text] [Related]
8. Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.
Wang M; Jokinen J; Tretyakova I; Pushko P; Lukashevich IS
Vaccine; 2018 Jan; 36(5):683-690. PubMed ID: 29287681
[TBL] [Abstract][Full Text] [Related]
9. Impact of a Plasmid DNA-Based Alphavirus Vaccine on Immunization Efficiency.
Lundstrom K
Methods Mol Biol; 2021; 2197():33-47. PubMed ID: 32827131
[TBL] [Abstract][Full Text] [Related]
10. Non-viral amplification systems for gene transfer: vectors based on alphaviruses.
Smerdou C; Liljeström P
Curr Opin Mol Ther; 1999 Apr; 1(2):244-51. PubMed ID: 11715947
[TBL] [Abstract][Full Text] [Related]
11. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
12. Alphavirus vectors for cancer gene therapy (review).
Yamanaka R
Int J Oncol; 2004 Apr; 24(4):919-23. PubMed ID: 15010830
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ
J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413
[TBL] [Abstract][Full Text] [Related]
14. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors.
Polo JM; Belli BA; Driver DA; Frolov I; Sherrill S; Hariharan MJ; Townsend K; Perri S; Mento SJ; Jolly DJ; Chang SM; Schlesinger S; Dubensky TW
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4598-603. PubMed ID: 10200308
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins.
Gorchakov R; Volkova E; Yun N; Petrakova O; Linde NS; Paessler S; Frolova E; Frolov I
Virology; 2007 Sep; 366(1):212-25. PubMed ID: 17507072
[TBL] [Abstract][Full Text] [Related]
16. Alphavirus DNA and particle replicons for vaccines and gene therapy.
Polo JM; Gardner JP; Ji Y; Belli BA; Driver DA; Sherrill S; Perri S; Liu MA; Dubensky TW
Dev Biol (Basel); 2000; 104():181-5. PubMed ID: 11713818
[TBL] [Abstract][Full Text] [Related]
17. Alphavirus vectors: development and potential therapeutic applications.
Schlesinger S
Expert Opin Biol Ther; 2001 Mar; 1(2):177-91. PubMed ID: 11727528
[TBL] [Abstract][Full Text] [Related]
18. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.
Hevey M; Negley D; Pushko P; Smith J; Schmaljohn A
Virology; 1998 Nov; 251(1):28-37. PubMed ID: 9813200
[TBL] [Abstract][Full Text] [Related]
19. Alphavirus-based vaccines.
Lundstrom K
Curr Opin Mol Ther; 2002 Feb; 4(1):28-34. PubMed ID: 11883692
[TBL] [Abstract][Full Text] [Related]
20. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.
Garmashova N; Gorchakov R; Volkova E; Paessler S; Frolova E; Frolov I
J Virol; 2007 Mar; 81(5):2472-84. PubMed ID: 17108023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
